stemodin: structure given in first source; isolated from Stemodia maritima; a major stemodane diterpene; RN given for (2alpha,5alpha,9beta,13alpha,17beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Stemodia | genus | [no description available] | Plantaginaceae | A plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 11012233 |
CHEMBL ID | 485073 |
MeSH ID | M0200750 |
Synonym |
---|
stemodin |
CHEMBL485073 |
41943-79-7 |
9,15-cyclo-c,18-dinor-14,15-secoandrostane-2,17-diol, 4,4,17-trimethyl-, (2alpha,5alpha,9beta,13alpha,17beta)- |
(1r,2s,4s,7s,10s,12s,13s)-2,6,6,13-tetramethyltetracyclo[10.3.1.01,10.02,7]hexadecane-4,13-diol |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID357847 | Antiviral activity against HSV1 in african green monkey Vero cells assessed as reduction in number of plaques at 0.02 mg/ml after 66 hrs | |||
AID357849 | Cytotoxicity against african green monkey Vero cells after 66 hrs | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |